Analysts Set BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Target Price at $11.00

Shares of BioXcel Therapeutics, Inc. (NASDAQ:BTAI – Get Free Report) have been given an average recommendation of “Hold” by the four ratings firms that are covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, one has given a hold rating and two have issued a buy rating on […]